Search Results - "WILLEY, CHRISTOPHER D"

Refine Results
  1. 1

    HPAanalyze: an R package that facilitates the retrieval and analysis of the Human Protein Atlas data by Tran, Anh Nhat, Dussaq, Alex M, Kennell, Jr, Timothy, Willey, Christopher D, Hjelmeland, Anita B

    Published in BMC bioinformatics (09-09-2019)
    “…The Human Protein Atlas (HPA) aims to map human proteins via multiple technologies including imaging, proteomics and transcriptomics. Access of the HPA data is…”
    Get full text
    Journal Article
  2. 2

    Understanding Drug Sensitivity and Tackling Resistance in Cancer by Tyner, Jeffrey W, Haderk, Franziska, Kumaraswamy, Anbarasu, Baughn, Linda B, Van Ness, Brian, Liu, Song, Marathe, Himangi, Alumkal, Joshi J, Bivona, Trever G, Chan, Keith Syson, Druker, Brian J, Hutson, Alan D, Nelson, Peter S, Sawyers, Charles L, Willey, Christopher D

    Published in Cancer research (Chicago, Ill.) (15-04-2022)
    “…Decades of research into the molecular mechanisms of cancer and the development of novel therapeutics have yielded a number of remarkable successes. However,…”
    Get full text
    Journal Article
  3. 3

    Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential by Stackhouse, Christian T, Gillespie, G Yancey, Willey, Christopher D

    Published in Cells (Basel, Switzerland) (28-10-2020)
    “…Glioblastoma (GBM) remains the most devastating primary central nervous system malignancy with a median survival of around 15 months. The past decades of…”
    Get full text
    Journal Article
  4. 4

    Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection by Barrett, Olivia Claire, Hackney, James R., McDonald, Andrew M., Willey, Christopher D., Bredel, Markus, Fiveash, John B.

    “…To assess the local recurrence rate of gross totally resected atypical meningiomas and evaluate for pathologic predictors of recurrence. All patients meeting…”
    Get full text
    Journal Article
  5. 5

    Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death by Britain, Colleen M, Holdbrooks, Andrew T, Anderson, Joshua C, Willey, Christopher D, Bellis, Susan L

    Published in Journal of ovarian research (05-02-2018)
    “…The ST6Gal-I sialyltransferase is upregulated in numerous cancers, and high expression of this enzyme correlates with poor patient prognosis in various…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer by Smithson, Mary, Irwin, Regina K., Williams, Gregory, McLeod, M. Chandler, Choi, E. Karen, Ganguly, Anutosh, Pepple, Ashley, Cho, Clifford S., Willey, Christopher D., Leopold, Judith, Hardiman, Karin M.

    Published in Neoplasia (New York, N.Y.) (01-03-2022)
    “…Treatment of locally advanced rectal cancer includes chemoradiation and surgery, but patient response to treatment is variable. Patients who have a complete…”
    Get full text
    Journal Article
  8. 8

    A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma by Eustace, Nicholas J., Anderson, Joshua C., Warram, Jason M., Widden, Hayley N., Pedersen, Rune T., Alrefai, Hasan, Patel, Zeel, Hicks, Patricia H., Placzek, William J., Gillespie, G. Yancey, Hjelmeland, Anita B., Willey, Christopher D.

    Published in Oncogene (12-11-2020)
    “…Glioblastoma (GBM) is an aggressive malignancy with limited effectiveness of standard of care therapies including surgery, radiation, and temozolomide…”
    Get full text
    Journal Article
  9. 9

    Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer by Nair, Sindhu, Trummell, Hoa Q, Rajbhandari, Rajani, Thudi, Nanda K, Nozell, Susan E, Warram, Jason M, Willey, Christopher D, Yang, Eddy S, Placzek, William J, Bonner, James A, Bredel, Markus

    Published in PloS one (18-02-2020)
    “…Epidermal growth factor receptor (EGFR) is a pro-tumorigenic receptor tyrosine kinase that facilitates growth for cancer cells that overexpress the receptor…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models by Albert, Jeffrey M, Cao, Carolyn, Kim, Kwang Woon, Willey, Christopher D, Geng, Ling, Xiao, Dakai, Wang, Hong, Sandler, Alan, Johnson, David H, Colevas, Alexander D, Low, Jennifer, Rothenberg, Mace L, Lu, Bo

    Published in Clinical cancer research (15-05-2007)
    “…Purpose: Poly(ADP-ribose) polymerase-1 (PARP-1) is the founding member of a family of enzymes that catalyze the addition of ADP-ribose units to proteins that…”
    Get full text
    Journal Article
  12. 12

    Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner by Duarte, Christine W, Willey, Christopher D, Zhi, Degui, Cui, Xiangqin, Harris, Jacqueline J, Vaughan, Laura Kelly, Mehta, Tapan, McCubrey, Raymond O, Khodarev, Nikolai N, Weichselbaum, Ralph R, Gillespie, G Yancey

    Published in PloS one (05-01-2012)
    “…Previous reports have implicated an induction of genes in IFN/STAT1 (Interferon/STAT1) signaling in radiation resistant and prosurvival tumor phenotypes in a…”
    Get full text
    Journal Article
  13. 13

    Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data by Dussaq, Alex M, Kennell, Jr, Timothy, Eustace, Nicholas J, Anderson, Joshua C, Almeida, Jonas S, Willey, Christopher D

    Published in PloS one (21-08-2018)
    “…Kinomics is an emerging field of science that involves the study of global kinase activity. As kinases are essential players in virtually all cellular…”
    Get full text
    Journal Article
  14. 14

    Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy by Yamada, Koshi, Huang, Zhi qiang, Raska, Milan, Reily, Colin, Anderson, Joshua C., Suzuki, Hitoshi, Kiryluk, Krzysztof, Gharavi, Ali G., Julian, Bruce A., Willey, Christopher D., Novak, Jan

    Published in Kidney diseases (01-05-2020)
    “…Objectives: IgA nephropathy (IgAN) is thought to involve an autoimmune process wherein galactose-deficient IgA1 (Gd-IgA1), recognized as autoantigen by…”
    Get full text
    Journal Article
  15. 15

    PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma by Marayati, Raoud, Stafman, Laura L., Williams, Adele P., Bownes, Laura V., Quinn, Colin H., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Anderson, Joshua C., Willey, Christopher D., Beierle, Elizabeth A.

    Published in Scientific reports (16-03-2021)
    “…Despite increasing incidence, treatment for hepatoblastoma has not changed significantly over the past 20 years. Chemotherapeutic strategies continue to rely…”
    Get full text
    Journal Article
  16. 16

    Fractionated stereotactic radiation therapy for intact brain metastases by Marcrom, Samuel R., MD, McDonald, Andrew M., MD, Thompson, Jonathan W., MD, Popple, Richard A., PhD, Riley, Kristen O., MD, Markert, James M., MD, Willey, Christopher D., MD, PhD, Bredel, Markus, MD, PhD, Fiveash, John B., MD

    Published in Advances in radiation oncology (01-10-2017)
    “…Abstract Purpose Limited data exist on fractionated stereotactic radiation therapy (FSRT) for brain metastases. We sought to evaluate the safety and efficacy…”
    Get full text
    Journal Article
  17. 17

    Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth by Zeng, Ling, Boggs, Drexell Hunter, Xing, Chuan, Zhang, Zhuo, Anderson, Joshua C., Wajapeyee, Narendra, Veale, Chris, Bredel, Markus, Shi, Lewis Z., Bonner, James A., Willey, Christopher D., Yang, Eddy S.

    Published in Frontiers in genetics (10-09-2020)
    “…Novel targeted agents to inhibit DNA repair pathways to sensitize tumors to irradiation (IR) are being investigated as an alternative to chemoradiation for…”
    Get full text
    Journal Article
  18. 18

    The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization by Rohrbach, Timothy D, Shah, Nishi, Jackson, William P, Feeney, Erin V, Scanlon, Samantha, Gish, Robert, Khodadadi, Ryan, Hyde, Stephen O, Hicks, Patricia H, Anderson, Joshua C, Jarboe, John S, Willey, Christopher D

    Published in PloS one (15-10-2015)
    “…Translocation to the nucleus of diacylglycerol kinase (DGK)- ζ is dependent on a sequence homologous to the effector domain of Myristoylated Alanine Rich…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Fibroblast growth factor receptor facilitates recurrence of minimal residual disease following trastuzumab emtansine therapy by Akhand, Saeed S., Chen, Hao, Purdy, Stephen Connor, Liu, Zian, Anderson, Joshua C., Willey, Christopher D., Wendt, Michael K.

    Published in NPJ breast cancer (21-01-2021)
    “…Trastuzumab-emtansine (T-DM1) is an antibody-drug conjugate (ADC) that efficiently delivers a highly potent microtubule inhibitor to HER2 overexpressing cells…”
    Get full text
    Journal Article